Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1
Patients co-infected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are at high risk for liver disease progression. However, interferon-based treatments for HCV infection have significant toxicities, limiting treatment uptake.To assess the all-oral 3 direct-acting antiviral (3D)...
Guardat en:
Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Idioma: | anglès |
Publicat: |
2015
|
Accés en línia: | https://doi.org/10.1001/jama.2015.1328 https://jamanetwork.com/journals/jama/articlepdf/2173265/joi150019.pdf |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|